Skip to main content
Equibles

Chris Pascual

Analyst

Nefron Research

Equibles does not estimate personal net worth.

About Chris Pascual

Chris Pascual is recorded as Analyst at Nefron Research. Chris Pascual has spoken on 1 earnings call across 1 company, most recently for Stryker Corp on January 29, 2026. The companies whose calls Chris Pascual spoke on are classified in the Healthcare sector.

Chris Pascual on recent calls

“So the pricing benefit you reported for MedSurg this quarter, I think it was the smallest we've seen since 2022. Was there anything sort of quirky about this quarter that drove that?”
Analyst — Nefron Research, Stryker Corp Q4 FY2025 Earnings Call ·

Affiliation history

  • Nefron Research

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity